DK3319952T3 - Fremgangsmåde til fremstilling af cannabidiol og delta-9-tetrahydrocannabinol - Google Patents

Fremgangsmåde til fremstilling af cannabidiol og delta-9-tetrahydrocannabinol Download PDF

Info

Publication number
DK3319952T3
DK3319952T3 DK16741447.3T DK16741447T DK3319952T3 DK 3319952 T3 DK3319952 T3 DK 3319952T3 DK 16741447 T DK16741447 T DK 16741447T DK 3319952 T3 DK3319952 T3 DK 3319952T3
Authority
DK
Denmark
Prior art keywords
tetrahydrocannabinol
delta
preparing cannabidiol
cannabidiol
preparing
Prior art date
Application number
DK16741447.3T
Other languages
English (en)
Inventor
Lukas Dialer
Denis Petrovic
Ulrich Weigl
Original Assignee
Purisys Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57730761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3319952(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Purisys Llc filed Critical Purisys Llc
Application granted granted Critical
Publication of DK3319952T3 publication Critical patent/DK3319952T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/14Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK16741447.3T 2015-07-10 2016-07-01 Fremgangsmåde til fremstilling af cannabidiol og delta-9-tetrahydrocannabinol DK3319952T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562191097P 2015-07-10 2015-07-10
US15/199,528 US10059683B2 (en) 2015-07-10 2016-06-30 Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
PCT/US2016/040635 WO2017011210A1 (en) 2015-07-10 2016-07-01 Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
DK3319952T3 true DK3319952T3 (da) 2020-03-23

Family

ID=57730761

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16741447.3T DK3319952T3 (da) 2015-07-10 2016-07-01 Fremgangsmåde til fremstilling af cannabidiol og delta-9-tetrahydrocannabinol

Country Status (21)

Country Link
US (4) US10059683B2 (da)
EP (2) EP3319952B8 (da)
JP (2) JP6810842B2 (da)
CN (1) CN108137526A (da)
AU (2) AU2016294264B2 (da)
BR (1) BR112018000497A2 (da)
CA (1) CA2992043C (da)
CL (2) CL2018000079A1 (da)
CO (1) CO2018001290A2 (da)
CR (1) CR20180094A (da)
DK (1) DK3319952T3 (da)
EC (1) ECSP18010065A (da)
ES (2) ES3010714T3 (da)
HK (1) HK1255390A1 (da)
IL (1) IL256750A (da)
MX (1) MX2018000354A (da)
MY (1) MY182971A (da)
NZ (1) NZ738925A (da)
PH (1) PH12018500093A1 (da)
PT (1) PT3319952T (da)
WO (1) WO2017011210A1 (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2531281A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
US10059683B2 (en) * 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
GB2564383B (en) 2017-06-23 2021-04-21 Gw Res Ltd Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
GB2568929A (en) 2017-12-01 2019-06-05 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
CA3091088A1 (en) * 2018-02-13 2019-08-22 Beetlebung Pharma Ltd. Cannabinoid derivatives and conjugates and uses thereof
HUE060229T2 (hu) * 2018-02-20 2023-02-28 Mymd Pharmaceuticals Inc Genetikailag módosított cannabis sativa növények és módosított kannabinoid vegyületek a kábítószer-függõség és más rendellenességek kezelésére
EP4620940A3 (en) 2018-06-28 2025-12-17 Symrise AG Synthesis of (+)-cannabinoids and their therapeutic effects
US10736869B2 (en) 2018-07-16 2020-08-11 ECS Health Sciences, Inc. Compositions and methods related to cannabinoids, terpenoids and essential oils
CN108863768A (zh) * 2018-08-03 2018-11-23 上海华堇生物技术有限责任公司 3,5-二甲氧基苯甲酰氯的制备方法
JP2021535203A (ja) * 2018-08-20 2021-12-16 ベッソール ファルマ、エルエルシー 既知および新規カンナビノイドの適用
WO2020051371A2 (en) * 2018-09-05 2020-03-12 Noramco, Inc. Cannabidiol compositions having modified cannabinoid profiles
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
EP3653596A1 (en) * 2018-11-14 2020-05-20 Indena S.p.A. Continuous flow synthesis of cannabidiol
DE102019104563A1 (de) 2019-02-22 2020-08-27 Chiracon Gmbh Verfahren zur Herstellung von Cannabidiol
CN109970516A (zh) * 2019-03-20 2019-07-05 栾云鹏 一种工业化制备高纯度高收率的大麻酚类物质的合成方法
US10981850B2 (en) 2019-04-15 2021-04-20 Trustees Of Boston University One-step flow-mediated synthesis of cannabidiol (CBD) and derivatives
CN111943813B (zh) * 2019-05-17 2023-04-14 上海特化医药科技有限公司 大麻二酚类化合物的制备方法
CA3179235A1 (en) * 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors
CA3142008A1 (en) * 2019-05-31 2020-12-03 Purisys Llc Processes for the preparation of halogenated dihydroxybenzene compounds
EP3983367B1 (en) 2019-06-11 2025-07-30 Symrise AG Synthesis and purification of cannabigerol and its application
WO2020248058A1 (en) 2019-06-11 2020-12-17 Canopy Growth Corporation Improved methods for converting cannabidiol into delta 8-tetrahydrocannabinol
WO2020252277A1 (en) * 2019-06-13 2020-12-17 Isomerz, Inc. Making delta 8 thc, delta 10 thc and/or cannabinol from cbd
US20220242810A1 (en) * 2019-06-14 2022-08-04 Purisys Llc Crystalline cannabigerol
GB201910389D0 (en) * 2019-07-19 2019-09-04 Gw Pharma Ltd Novel compounds, methods for their manufacture, and uses thereof
AU2020345656A1 (en) 2019-09-09 2022-04-21 Kare Chemical Technologies Inc. Cannabinoid derivatives, precursors and uses
US11542243B1 (en) 2019-09-26 2023-01-03 FusionFarms, LLC Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
WO2021113083A1 (en) 2019-12-06 2021-06-10 JLABS Beauty LLC Topical compositions containing rose oil and cannabidiol and methods of making and using the same
JP7761564B2 (ja) * 2019-12-27 2025-10-28 ベイメディカ インコーポレイテッド カンナビクロメンおよび関連するカンナビノイドの調製法
EP4089081B1 (en) * 2020-01-08 2025-07-23 Chengdu Baiyu Pharmaceutical Co., Ltd. Tetrahydrocannabinol derivative, and preparation method therefor and medical use thereof
CN113087599A (zh) * 2020-01-08 2021-07-09 成都百裕制药股份有限公司 大麻二酚衍生物及其制备方法和在医药上的应用
WO2021139739A1 (zh) * 2020-01-08 2021-07-15 成都百裕制药股份有限公司 大麻二酚衍生物及其制备方法和在医药上的应用
WO2021150885A1 (en) * 2020-01-24 2021-07-29 Perkinelmer Health Sciences, Inc. Cannabinoid derivatives
US10981849B1 (en) * 2020-02-20 2021-04-20 Sci Pharmtech Inc. Method for preparing cannabinoids
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
WO2021181420A1 (en) 2020-03-12 2021-09-16 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Process for the synthesis of cannabidiol and intermediates thereof
BR112022019616A2 (pt) 2020-03-31 2022-12-06 Phytotherapeutix Ltd Compostos terpenofenólicos e seu uso
CA3179442A1 (en) 2020-05-22 2021-11-25 Brian Warrington Compositions for treating acne and dermatological conditions
CN112094257B (zh) * 2020-08-19 2023-08-22 公安部禁毒情报技术中心 一种△-9四氢大麻酚的制备方法
CN112811980B (zh) * 2020-12-01 2022-03-25 山东金城金奥医药科技有限公司 一种绿色光氧化连续制备大麻二酚中间体的方法
CA3205594A1 (en) 2020-12-17 2022-06-23 Nalu Bio, Inc. Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use
JP2024500187A (ja) 2020-12-21 2024-01-04 アイソセレス ファーマシューティカルズ,インコーポレイテッド 非経口カンナビノイド配合物およびその使用
US11242328B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans
US11242330B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Organic catalyst and method for preparation of aromatic tricyclic pyrans
US20220306598A1 (en) * 2021-03-25 2022-09-29 Precision Extraction Corporation Method for highly selective conversion of cbd to delta-8 thc
GB2628746A (en) * 2021-03-31 2024-10-02 Phytotherapeutix Ltd Terpenophenolic compounds and their use
US11352337B1 (en) * 2021-06-02 2022-06-07 Acid Neutral Alkaline Laboratory Zeolite catalyst and method for preparation of aromatic tricyclic pyrans
CN113603568A (zh) * 2021-07-19 2021-11-05 厦门朝阳生物工程有限公司 一种大麻二酚的制备方法
WO2023086447A2 (en) * 2021-11-12 2023-05-19 Pureform Global, Inc. A method for the synthesis of cannabinol
US20260049067A1 (en) 2022-08-05 2026-02-19 Salud & Semillas, S.L. CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl 3 * 6H2O AS CATALYST
WO2024031176A1 (en) 2022-08-11 2024-02-15 Cardiol Therapeutics Inc. Stable injectable cannabidiol formulations
CN117700304A (zh) * 2022-09-01 2024-03-15 卡那比生物科学有限公司 一种大麻二酚的制备方法及其应用
GB2642523A (en) * 2024-07-12 2026-01-14 Sonas Pharmaceuticals N I Ltd Novel halogenated cannabinoid derivatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473075A (de) 1966-11-04 1969-05-31 Theodor Dr Petrzilka Verfahren zur Herstellung von in 2-Stellung substituierten Resorcinderivaten
DE4100441A1 (de) 1991-01-09 1992-07-16 Mack Chem Pharm Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol
WO2001003690A1 (en) 1999-07-12 2001-01-18 Virginia Commonwealth University Novel vasodilator cannabinoid analogs
EP1482917B1 (en) * 2002-02-01 2019-05-08 GW Pharma Limited Compositions comprising cannabidiolic acid for treatment of nausea, vomiting, emesis, motion sickness or like conditions
GB2393182B (en) * 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
CN1809552A (zh) * 2003-05-20 2006-07-26 田纳西大学研究基金会 大麻素衍生物、其制备方法和用途
US7323576B2 (en) 2004-10-01 2008-01-29 Alphora Research Inc. Synthetic route to dronabinol
TWI369203B (en) * 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
DE102005028937B4 (de) * 2005-06-22 2009-07-23 Bionorica Ag Verfahren zur Herstellung von Dronabinol
CA2623723A1 (en) * 2005-09-29 2007-04-12 Amr Technology, Inc. Process for production of delta-9-tetrahydrocannabinol
CA2751741C (en) * 2008-02-06 2018-07-10 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
PL3274321T3 (pl) * 2015-03-23 2020-03-31 Echo Pharmaceuticals B.V. Izolat kannabidiolu z konopi przemysłowych i jego zastosowanie w preparatach farmaceutycznych i/lub kosmetycznych
CA2986268C (en) * 2015-05-28 2024-01-02 Insys Development Company, Inc. Stable cannabinoid formulations
US10059683B2 (en) * 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Also Published As

Publication number Publication date
AU2016294264A1 (en) 2018-02-01
AU2016294264B2 (en) 2019-06-13
ECSP18010065A (es) 2018-05-31
PH12018500093A1 (en) 2018-07-09
JP2018522944A (ja) 2018-08-16
WO2017011210A1 (en) 2017-01-19
CA2992043A1 (en) 2017-01-19
EP3722276A1 (en) 2020-10-14
JP2020037596A (ja) 2020-03-12
US10059683B2 (en) 2018-08-28
EP3319952B1 (en) 2020-02-05
EP3319952B8 (en) 2020-03-11
CN108137526A (zh) 2018-06-08
MY182971A (en) 2021-02-05
ES2784881T3 (es) 2020-10-01
AU2019229416A1 (en) 2019-10-03
EP3722276C0 (en) 2025-01-08
MX2018000354A (es) 2018-08-15
ES3010714T3 (en) 2025-04-04
CL2019003154A1 (es) 2020-03-06
CR20180094A (es) 2018-06-14
US10844035B2 (en) 2020-11-24
US20180319763A1 (en) 2018-11-08
BR112018000497A2 (pt) 2018-09-11
NZ738925A (en) 2019-05-31
IL256750A (en) 2018-03-29
CL2018000079A1 (es) 2018-08-24
US20170008869A1 (en) 2017-01-12
PT3319952T (pt) 2020-04-22
EP3722276B1 (en) 2025-01-08
JP6810842B2 (ja) 2021-01-13
CA2992043C (en) 2020-04-14
US20210061781A1 (en) 2021-03-04
CO2018001290A2 (es) 2018-04-19
HK1255390A1 (zh) 2019-08-16
EP3319952A1 (en) 2018-05-16
US20170008868A1 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
DK3319952T3 (da) Fremgangsmåde til fremstilling af cannabidiol og delta-9-tetrahydrocannabinol
IL259305B1 (en) Additive manufacturing apparatus, system, and method
DK3212189T3 (da) Substituerede chromaner og fremgangsmåde til anvendelse deraf
IL253576B (en) Methods of purifying cannabinoids, compositions and kits thereof
IL255826B (en) Printing system and method
DK3337704T3 (da) Fremgangsmåde og system til styring af køretøjsstabilitet, og køretøj
DK3265947T3 (da) Fremgangsmåde og system til kryptering
DK3259386T3 (da) Systemer og fremgangsmåder til udførelse af immunoassays
DK3129912T3 (da) Fremgangsmåde og system til sikring af data
DK3205119T3 (da) Høreapparat system og metode
DK3359281T3 (da) Fremgangsmåde til udtrækning af CO2
DK3304767T3 (da) Fremgangsmåde og system til overvågning af en flyvemaskinestatus
DK3191809T3 (da) System og fremgangsmåde til fremstilling af en farmaceutisk forbindelse
DK3134149T3 (da) Mikrokanyler og fremgangsmåder til fremstilling deraf
IL257268A (en) Botanical identification method and system
DK3368447T3 (da) Kapsel, system og fremgangsmåde til tilberedning af en drikkevare
DK3288553T3 (da) Kombinationer af cannabinoider og n-acylethanolaminer
DK3189391T3 (da) System og fremgangsmåde til optimering af vindmølledrift
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
IL259707B (en) Conveyance system and conveyance method
DK3347113T3 (da) Ekstraktionsapparat og metode dertil
DK3230917T3 (da) System og fremgangsmåde til aktivering af sikker autentificering
DK3397748T3 (da) Fremgangsmåde til dyrkning og konservering af Eubacterium hallii
DK3178324T3 (da) Mikrobicid og fremgangsmåde til fremstilling af samme
DK3563733T3 (da) Fremgangsmåde til tilberedning af en drikkevare og en indretning til tilberedning af en drikkevare